Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
J Biochem
2013 Jan 01;1531:51-61. doi: 10.1093/jb/mvs118.
Show Gene links
Show Anatomy links
Roles of CUB and LDL receptor class A domain repeats of a transmembrane serine protease matriptase in its zymogen activation.
Inouye K
,
Tomoishi M
,
Yasumoto M
,
Miyake Y
,
Kojima K
,
Tsuzuki S
,
Fushiki T
.
Abstract
Matriptase is a type II transmembrane serine protease containing two complement proteases C1r/C1s-urchin embryonic growth factor-bone morphogenetic protein domains (CUB repeat) and four low-density lipoprotein receptor class A domains (LDLRA repeat). The single-chain zymogen of matriptase has been found to exhibit substantial protease activity, possibly causing its own activation (i.e. conversion to a disulfide-linked two-chain fully active form), although the activation seems to be mediated predominantly by two-chain molecules. Our aim was to assess the roles of CUB and LDLRA repeats in zymogen activation. Transient expression studies of soluble truncated constructs of recombinant matriptase in COS-1 cells showed that the CUB repeat had an inhibitory effect on zymogen activation, possibly because it facilitated the interaction of two-chain molecules with a matriptase inhibitor, hepatocyte growth factor activator inhibitor type-1. By contrast, the LDLRA repeat had a promoting effect on zymogen activation. The effect of the LDLRA repeat seems to reflect its ability to increase zymogen activity. The proteolytic activities were higher in pseudozymogen forms of recombinant matriptase containing the LDLRA repeat than in a pseudozymogen without the repeat. Our findings provide new insights into the roles of these non-catalytic domains in the generation of active matriptase.
Bork,
The CUB domain. A widespread module in developmentally regulated proteins.
1993, Pubmed
Bork,
The CUB domain. A widespread module in developmentally regulated proteins.
1993,
Pubmed
Bugge,
Matriptase-dependent cell surface proteolysis in epithelial development and pathogenesis.
2007,
Pubmed
Darragh,
MT-SP1 proteolysis and regulation of cell-microenvironment interactions.
2008,
Pubmed
Désilets,
Mutation G827R in matriptase causing autosomal recessive ichthyosis with hypotrichosis yields an inactive protease.
2008,
Pubmed
Fass,
Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module.
1997,
Pubmed
Friedrich,
Catalytic domain structures of MT-SP1/matriptase, a matrix-degrading transmembrane serine proteinase.
2002,
Pubmed
Inouye,
The optimal activity of a pseudozymogen form of recombinant matriptase under the mildly acidic pH and low ionic strength conditions.
2010,
Pubmed
Inouye,
Identification of the matriptase second CUB domain as the secondary site for interaction with hepatocyte growth factor activator inhibitor type-1.
2010,
Pubmed
Kim,
Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains.
1999,
Pubmed
Kojima,
Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase.
2008,
Pubmed
Kojima,
The activity of a type II transmembrane serine protease, matriptase, is dependent solely on the catalytic domain.
2009,
Pubmed
Laemmli,
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
1970,
Pubmed
Lee,
Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease.
2000,
Pubmed
Lee,
Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain.
2007,
Pubmed
Lin,
Zymogen activation, inhibition, and ectodomain shedding of matriptase.
2008,
Pubmed
List,
Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis.
2006,
Pubmed
List,
Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway.
2009,
Pubmed
List,
Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis.
2002,
Pubmed
Miyake,
Activation of a membrane-bound serine protease matriptase on the cell surface.
2009,
Pubmed
Miyake,
Requirement of the activity of hepatocyte growth factor activator inhibitor type 1 for the extracellular appearance of a transmembrane serine protease matriptase in monkey kidney COS-1 cells.
2009,
Pubmed
Moestrup,
The alpha 2-macroglobulin receptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands.
1994,
Pubmed
Netzel-Arnett,
Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation.
2006,
Pubmed
Oberst,
The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor.
2003,
Pubmed
Satomi,
A role for membrane-type serine protease (MT-SP1) in intestinal epithelial turnover.
2001,
Pubmed
Takeuchi,
Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue.
1999,
Pubmed
Takeuchi,
Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates.
2000,
Pubmed
Thielens,
The N-terminal CUB-epidermal growth factor module pair of human complement protease C1r binds Ca2+ with high affinity and mediates Ca2+-dependent interaction with C1s.
1999,
Pubmed
Tseng,
Matriptase activation, an early cellular response to acidosis.
2010,
Pubmed
Tsuzuki,
Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes.
2005,
Pubmed
Wang,
Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition.
2009,
Pubmed
Williams,
Zymogen/enzyme discrimination using peptide chloromethyl ketones.
1989,
Pubmed
